Here are five key points:
1. The market is expected to reach $34.57 billion by 2022, up from $18.26 billion in 2015.
2. Technological advancements and a large geriatric population will spur market growth.
3. Poor reimbursements will hinder market growth.
4. Zimmer Biomet leads the market.
5. Other key players include B. Braun/Aesculap, ConforMIS, Corin, DJO Hip, Exactech, Johnson & Johnson, Mathys AG, Medacta, MicroPort Orthopedics, Smith & Nephew, Stryker, Think Surgical, Waldemar LINK and Wright Medical.
More articles on devices:
St. Jude Medical shares increase 0.32%— 4 notes
Histogenics acquires sole development, marketing rights for NeoCart in Japan: 5 key notes
Study: Cartiva SCI an effective for toe osteoarthritis treatment — 4 points
At the Becker’s 32nd Annual Meeting: The Business and Operations of ASCs, taking place October 29-31 in Chicago, ASC leaders, surgeons and healthcare executives will explore strategies to drive growth, enhance operational performance, navigate reimbursement challenges and prepare for the future of ambulatory surgery. Apply for complimentary registration now.
